#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
A fibrosarcoma is a cancerous soft tissue tumor that originates in the connective fibrous tissue found at the ends of arm and leg bones; it then spreads to other surrounding soft tissues. Fibrosarcoma usually affects either a lower leg or arm.
There are two forms of fibrosarcoma:
Children with fibrosarcoma are treated through the Bone and Soft Tissue Tumor Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Our integrated program offers the combined expertise of a leading cancer center and a world-renown children’s hospital.
Find in-depth information on fibrosarcoma on the Dana-Farber/Boston Children's website, including details on fibrosarcoma symptoms, diagnosis, treatment and research.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”